Mitzi Chang

Work for clients:

Public offerings

• aTyr Pharma, Inc. in its $75 million initial public offering and $35 million at-the-market offering
• Fate Therapeutics, Inc. in its $40 million initial public offering, $30 million follow-on public offering, $8 million private placement with Juno Therapeutics and PIPE transactions totaling $67 million
• Imperva in its $90 million initial public offering
• Various underwriters in connection with a $43 million follow-on offering for Regulus Therapeutics
• Anthera Pharmaceuticals, Inc. in its $42 million initial public offering and $31.5 million PIPE transaction
• A biopharmaceutical company in its $9 million follow-on public offering
• A nanotechnology holding company in its $8 million registered direct offering

Mergers and acquisitions

• Teva Pharmaceuticals Industries, Ltd. in its $3.2 billion acquisition of Auspex Pharmaceuticals, Inc.
• ECG Management Consultants, Inc. in its recapitalization by Gryphon Investors
• Spotlite, Inc. in its sale to Rally Health
• Onyx Pharmaceuticals, Inc. in its $10.4 billion sale to Amgen
• Courier Corporation in its acquisition of FastPencil, Inc.
• Location Labs in its sale to AVG Technologies
• InsightsOne Systems, Inc. in its sale to Apigee Corporation
• A startup company in a “spin-in” transaction with a publicly traded technology company
• Companies in acquihire transactions with Facebook, Google, Yahoo!, and Ebay
• Whiskey Media in its sale transactions with CBS Interactive and BermanBraun
• NeuroFocus, Inc. in its sale to Nielsen Holdings, N.V.

Financing transactions

• Greycroft Partners in various growth-equity investments, including Yeahka, a Chinese mobile payment service provider, and Performance Horizon Group Limited, a UK SaaS marketing platform
• Thomvest Ventures in various investments, including in Apsalar, Avalanche Technology, Netbase and Tactus Technology.
• IVP in its investment in Woven
• Ayla Networks in its Series C preferred stock financing
• WePay in its $40 million Series D preferred stock financing
• ThredUp, Inc. in its $81 million Series E preferred stock financing
• RocketLawyer in its preferred stock financings
• Industry Ventures in is investment in TheRealReal
• aTyr Pharma, Inc. in its $76 million Series E preferred stock financing
• Royalty Pharma in its purchases of royalties in various transactions
• TA Associates in its investment in Millennium Laboratories, Inc.
• LLM Capital Partners in its investment in Hybrid Design Associates, LLC
• Pipeline Angels in close to 20 portfolio investments